SK281390B6 - 2,3,4,5-tetrahydro-1h-benzazepíny, spôsob ich prípravy, farmaceutický prostriedok a použitie - Google Patents
2,3,4,5-tetrahydro-1h-benzazepíny, spôsob ich prípravy, farmaceutický prostriedok a použitie Download PDFInfo
- Publication number
- SK281390B6 SK281390B6 SK1000-94A SK100094A SK281390B6 SK 281390 B6 SK281390 B6 SK 281390B6 SK 100094 A SK100094 A SK 100094A SK 281390 B6 SK281390 B6 SK 281390B6
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- formula
- tetrahydro
- chloro
- benzazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK92233A DK23392D0 (da) | 1992-02-24 | 1992-02-24 | Heterocykliske forbindelser, deres anvendelse og fremstilling |
| PCT/DK1993/000041 WO1993017012A1 (en) | 1992-02-24 | 1993-02-05 | 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK100094A3 SK100094A3 (en) | 1995-04-12 |
| SK281390B6 true SK281390B6 (sk) | 2001-03-12 |
Family
ID=8091236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1000-94A SK281390B6 (sk) | 1992-02-24 | 1993-02-05 | 2,3,4,5-tetrahydro-1h-benzazepíny, spôsob ich prípravy, farmaceutický prostriedok a použitie |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0628039B1 (ru) |
| JP (1) | JPH07504172A (ru) |
| KR (1) | KR100255739B1 (ru) |
| AT (1) | ATE152450T1 (ru) |
| AU (1) | AU667878B2 (ru) |
| BG (1) | BG62208B1 (ru) |
| CA (1) | CA2130678C (ru) |
| CZ (1) | CZ288626B6 (ru) |
| DE (1) | DE69310353T2 (ru) |
| DK (2) | DK23392D0 (ru) |
| ES (1) | ES2102019T3 (ru) |
| FI (1) | FI113770B (ru) |
| GR (1) | GR3023896T3 (ru) |
| HU (1) | HU221314B1 (ru) |
| IL (1) | IL104657A (ru) |
| NO (1) | NO310193B1 (ru) |
| NZ (1) | NZ249465A (ru) |
| RO (1) | RO116088B1 (ru) |
| RU (1) | RU2114839C1 (ru) |
| SK (1) | SK281390B6 (ru) |
| UA (1) | UA34451C2 (ru) |
| WO (1) | WO1993017012A1 (ru) |
| ZA (1) | ZA931099B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0750616T3 (da) * | 1994-03-16 | 2001-07-23 | Cenes Ltd | Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser |
| AU700596B2 (en) * | 1995-09-15 | 1999-01-07 | Cenes Limited | Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
| GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
| DK2912019T3 (da) | 2012-10-25 | 2021-05-25 | Tetra Discovery Partners Llc | Heteroarylhæmmere af pde4 |
| US20150086480A1 (en) * | 2013-09-26 | 2015-03-26 | Tetra Discovery Partners, LLC | Heteroaryl inhibitors of pde4 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
| DK325188D0 (da) * | 1988-06-15 | 1988-06-15 | Novo Industri As | Hidtil ukendte benzazepinderivater |
| DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
-
1992
- 1992-02-24 DK DK92233A patent/DK23392D0/da not_active Application Discontinuation
-
1993
- 1993-02-05 HU HU9402434A patent/HU221314B1/hu not_active IP Right Cessation
- 1993-02-05 DK DK93905215.5T patent/DK0628039T3/da active
- 1993-02-05 KR KR1019940702944A patent/KR100255739B1/ko not_active IP Right Cessation
- 1993-02-05 NZ NZ249465A patent/NZ249465A/en unknown
- 1993-02-05 ES ES93905215T patent/ES2102019T3/es not_active Expired - Lifetime
- 1993-02-05 WO PCT/DK1993/000041 patent/WO1993017012A1/en active IP Right Grant
- 1993-02-05 AT AT93905215T patent/ATE152450T1/de not_active IP Right Cessation
- 1993-02-05 EP EP93905215A patent/EP0628039B1/en not_active Expired - Lifetime
- 1993-02-05 CA CA002130678A patent/CA2130678C/en not_active Expired - Fee Related
- 1993-02-05 CZ CZ19941988A patent/CZ288626B6/cs not_active IP Right Cessation
- 1993-02-05 AU AU36265/93A patent/AU667878B2/en not_active Ceased
- 1993-02-05 SK SK1000-94A patent/SK281390B6/sk unknown
- 1993-02-05 RO RO94-01400A patent/RO116088B1/ro unknown
- 1993-02-05 RU RU94040719A patent/RU2114839C1/ru not_active IP Right Cessation
- 1993-02-05 DE DE69310353T patent/DE69310353T2/de not_active Expired - Fee Related
- 1993-02-05 JP JP5514460A patent/JPH07504172A/ja active Pending
- 1993-02-05 UA UA94085741A patent/UA34451C2/ru unknown
- 1993-02-09 IL IL10465793A patent/IL104657A/en not_active IP Right Cessation
- 1993-02-17 ZA ZA931099A patent/ZA931099B/xx unknown
-
1994
- 1994-08-22 BG BG98993A patent/BG62208B1/bg unknown
- 1994-08-23 FI FI943875A patent/FI113770B/fi not_active IP Right Cessation
- 1994-08-24 NO NO19943123A patent/NO310193B1/no not_active IP Right Cessation
-
1997
- 1997-06-26 GR GR970401543T patent/GR3023896T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7250531B2 (en) | Process for the synthesis and crystalline form of agomelatine | |
| US20060264418A1 (en) | 6-(2,2,2-Trifluoroethylamino-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d] azephine as a 5-ht2c receptor agonist | |
| US20080033054A1 (en) | Process for preparing memantine hydrochloride substantially free of impurities | |
| SK281390B6 (sk) | 2,3,4,5-tetrahydro-1h-benzazepíny, spôsob ich prípravy, farmaceutický prostriedok a použitie | |
| LT3960B (en) | Process for preparing hypoglycemic compounds | |
| US5010074A (en) | Novel benzazepine derivatives | |
| US5470850A (en) | 2,3,4,5-tetrahydro-1H-3-benzazepines | |
| EP0233049A1 (en) | 2,3,4,8,9,9a-Hexahydro-4-aryl-1H-indeno[1,7-cd]azepines | |
| JPH02115166A (ja) | ピリジルケトオキシムエーテル誘導体 | |
| US3647877A (en) | Aminopropionanilides | |
| US20090076039A1 (en) | Deuterium-enriched valacyclovir | |
| KR100226328B1 (ko) | 4-(4-또는6-(트리플루오로메틸-2-피리디닐))-1-피페라지닐알킬치환된락탐 | |
| EP0288185B1 (en) | Thiadiazole guanidines | |
| WO2008157657A1 (en) | Deuterium-enriched tenofovir | |
| US20090062331A1 (en) | Deuterium-enriched maraviroc | |
| RU2033414C1 (ru) | Производные 4,5,6,7-тетрагидробензимидазола | |
| US20110144174A1 (en) | Deuterium-enriched odansetron | |
| JPH07103097B2 (ja) | オキシサリチルアミド誘導体 | |
| US20090076082A1 (en) | Deuterium-enriched alvimopan | |
| US20080299218A1 (en) | Deuterium-enriched valsartan | |
| DK163993B (da) | 5,7,8-substituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, fremstilling af disse, samt farmaceutiske praeparater indeholdende disse |